| Schedule of Disaggregated Revenue |
The following table presents our disaggregated revenue for the periods presented (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
MRD revenue |
|
|
|
|
|
|
|
|
|
|
|
|
Service revenue |
|
$ |
44,438 |
|
|
$ |
32,284 |
|
|
$ |
83,659 |
|
|
$ |
60,410 |
|
Regulatory milestone revenue |
|
|
5,500 |
|
|
|
3,000 |
|
|
|
10,000 |
|
|
|
7,500 |
|
Total MRD revenue |
|
|
49,938 |
|
|
|
35,284 |
|
|
|
93,659 |
|
|
|
67,910 |
|
Immune Medicine revenue |
|
|
|
|
|
|
|
|
|
|
|
|
Service revenue |
|
|
5,001 |
|
|
|
6,148 |
|
|
|
10,123 |
|
|
|
10,707 |
|
Collaboration revenue |
|
|
3,940 |
|
|
|
1,758 |
|
|
|
7,540 |
|
|
|
6,446 |
|
Total Immune Medicine revenue |
|
|
8,941 |
|
|
|
7,906 |
|
|
|
17,663 |
|
|
|
17,153 |
|
Total revenue |
|
$ |
58,879 |
|
|
$ |
43,190 |
|
|
$ |
111,322 |
|
|
$ |
85,063 |
|
|